317 related articles for article (PubMed ID: 23460311)
1. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
[TBL] [Abstract][Full Text] [Related]
2. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
Czader M; Ali SZ
Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
[TBL] [Abstract][Full Text] [Related]
4. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
Kaur K; Patel T; Patra S; Trivedi P
Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
[TBL] [Abstract][Full Text] [Related]
5. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
[TBL] [Abstract][Full Text] [Related]
6. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
[TBL] [Abstract][Full Text] [Related]
7. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center.
Patel T; Patel P; Mehta S; Shah M; Jetly D; Khanna N
Diagn Cytopathol; 2019 Aug; 47(8):776-782. PubMed ID: 31091023
[TBL] [Abstract][Full Text] [Related]
8. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
9. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
[TBL] [Abstract][Full Text] [Related]
11. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions.
Zeppa P; Marino G; Troncone G; Fulciniti F; De Renzo A; Picardi M; Benincasa G; Rotoli B; Vetrani A; Palombini L
Cancer; 2004 Feb; 102(1):55-65. PubMed ID: 14968418
[TBL] [Abstract][Full Text] [Related]
13. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin heavy-chain fluorescence in situ hybridization-chromogenic in situ hybridization DNA probe split signal in the clonality assessment of lymphoproliferative processes on cytological samples.
Zeppa P; Sosa Fernandez LV; Cozzolino I; Ronga V; Genesio R; Salatiello M; Picardi M; Malapelle U; Troncone G; Vigliar E
Cancer Cytopathol; 2012 Dec; 120(6):390-400. PubMed ID: 22517675
[TBL] [Abstract][Full Text] [Related]
16. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
[TBL] [Abstract][Full Text] [Related]
17. Significance of pericellular lacunae in cell blocks of effusions.
Price BA; Ehya H; Lee JH
Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.
Lonardi S; Manera C; Marucci R; Santoro A; Lorenzi L; Facchetti F
Diagn Cytopathol; 2011 May; 39(5):313-7. PubMed ID: 21488172
[TBL] [Abstract][Full Text] [Related]
19. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
Erkiliç S; Koçer NE
Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
